title: Enhanced expression of Runx2/PEBP2alphaA/CBFA1/AML3 during fracture healing.
abstract: The cause of the dramatic increase in expression of the osteopontin gene during fracture healing was studied in a mouse experimental model. Semiquantitative reverse transcription-polymerase chain reaction, Northern blotting, and in situ hybridization analysis showed that the enhanced expression took place prior to callus formation. The change in the expression pattern of collagenous and noncollagenous bone matrix proteins in addition to Ets-1 and Runx2, major transcription factors of osteopontin, were examined and compared to that of osteopontin. Although Ets-1 expression showed no significant change during fracture healing, enhanced expression of Runx2 corresponding to that of osteopontin was observed. Furthermore, in situ hybridization demonstrated that osteopontin-expressing cells also express the Runx2 gene. The results indicated the possibility that Runx2 is a major regulator of osteopontin during fracture healing.
authors.affiliation: Department of Pathology, Osaka University Medical School, Osaka, Japan.
authors.forename: Hirohisa
authors.initials: H
authors.lastname: Kawahata
authors.forename: Toru
authors.initials: T
authors.lastname: Kikkawa
authors.forename: Yuji
authors.initials: Y
authors.lastname: Higashibata
authors.forename: Takahiko
authors.initials: T
authors.lastname: Sakuma
authors.forename: Martin
authors.initials: M
authors.lastname: Huening
authors.forename: Motohiko
authors.initials: M
authors.lastname: Sato
authors.forename: Mizuo
authors.initials: M
authors.lastname: Sugimoto
authors.forename: Kohji
authors.initials: K
authors.lastname: Kuriyama
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Terai
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Kitamura
authors.forename: Shintaro
authors.initials: S
authors.lastname: Nomura
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D055396:Bone Morphogenetic Protein 2; D055415:Bone Morphogenetic Protein 4; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D024042:Collagen Type I / Q000378:metabolism; D050659:Core Binding Factor Alpha 1 Subunit; D017102:Fracture Healing / Q000502:physiology*; D017403:In Situ Hybridization; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009363:Neoplasm Proteins; D053495:Osteopontin; D050784:Proto-Oncogene Protein c-ets-1; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D050783:Proto-Oncogene Proteins c-ets; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012795:Sialoglycoproteins / Q000235:genetics; D014157:Transcription Factors / Q000378:metabolism*; D016212:Transforming Growth Factor beta
chemical_list: C525719:Bmp2 protein, mouse; C525810:Bmp4 protein, mouse; D055396:Bone Morphogenetic Protein 2; D055415:Bone Morphogenetic Protein 4; D019485:Bone Morphogenetic Proteins; D024042:Collagen Type I; D050659:Core Binding Factor Alpha 1 Subunit; C494042:Ets1 protein, mouse; D009363:Neoplasm Proteins; D050784:Proto-Oncogene Protein c-ets-1; D011518:Proto-Oncogene Proteins; D050783:Proto-Oncogene Proteins c-ets; D012795:Sialoglycoproteins; C506896:Spp1 protein, mouse; D014157:Transcription Factors; D016212:Transforming Growth Factor beta; D053495:Osteopontin